Comparison of the response to HBS Ag vaccine in chronic renal failure patients with different GFR levels
Phase 1
- Conditions
- Chronic renal failure.Chronic renal failure
- Registration Number
- IRCT138803121267N8
- Lead Sponsor
- rology and Nephrology Research Center (UNRC), Shahid Beheshti University, M.C.( SBMU), Tehran, I.R.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Presence of Chronic Renal Failure, age between 18 and 85 yea, negative HBS Ab,
Exclusion criteria: Receiving immunosuppressive drug, previous HBV vaccinations
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HBS Ab. Timepoint: 4-8 weeks after the latest vaccine dose. Method of measurement: lab test.
- Secondary Outcome Measures
Name Time Method